CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 31 filers reported holding CORREVIO PHARMA CORP in Q4 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $120,000 | -7.7% | 60,280 | 0.0% | 0.00% | – |
| Q2 2019 | $130,000 | -27.8% | 60,280 | +6.0% | 0.00% | – |
| Q1 2019 | $180,000 | +28.6% | 56,880 | +1.7% | 0.00% | – |
| Q4 2018 | $140,000 | -36.4% | 55,940 | +2.3% | 0.00% | – |
| Q3 2018 | $220,000 | +4.8% | 54,660 | -2.0% | 0.00% | – |
| Q2 2018 | $210,000 | – | 55,760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|